Skip to main content
Premium Trial:

Request an Annual Quote

Biothreat Detection Tech Firm BioFlyte Raises $6.1M in Series A Round

NEW YORK — Biothreat detection technology firm BioFlyte said on Tuesday that it has raised $6.1 million in Series A funding.

The financing round was led by Cottonwood Technology Fund and included existing investor Anzu Partners.

Albuquerque, New Mexico-based BioFlyte was spun off in 2020 from Zeteo Tech, which develops environmental air testing technologies, to commercialize systems for detecting SARS-CoV-2 and other airborne pathogens.

BioFlyte said that it will use the Series A money to support the field validation and initial production of BioTOF z200, a matrix-assisted laser desorption and ionization mass spectrometry-based bio-aerosol detection system for continuous and autonomous operation in critical infrastructure environments. The system consists of a wall mount sensor designed to detect and identify airborne microbes and toxins in real time, the company said. It is expected to launch commercially before the end of the year.

BioFlyte previously raised $1.25 million in seed funding.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.